| T1DM N = 77 | T2DM | Total N = 381 | ||||
Diet and exercise N = 2 | OGLD treatment N = 187 | Insulin treatment N = 27 | OGLD + Insulin treatment N = 88 | Total N = 304 | |||
People tested for HbA1c | 58 (80.56) | 2 (100.00) | 118 (68.60) | 20 (80.00) | 64 (76.19) | 204 (72.08) | 262 (73.80) |
Frequency of tests for HbA1c during past year | 1.59 (1.19) | 2.00 (0.00) | 1.30 (0.69) | 1.26 (0.73) | 1.32 (0.68) | 1.31 (0.69) | 1.37 (0.83) |
Value of last HbA1c measurement (%) | 9.17 (2.19) | 6.20 (0.28) | 7.81 (2.35) | 9.19 (2.45) | 9.45 (2.55) | 8.44 (2.53) | 8.60 (2.48) |
No. of people achieving HbA1c < 7% | 6 (10.71) | 2 (100.00) | 48 (41.03) | 4 (21.05) | 12 (18.75) | 66 (32.67) | 72 (27.91) |
Last FBG measurement (mg/dl) | 145.06 (69.29) | 92.65 (31.75) | 136.07 (59.77) | 149.94 (71.38) | 145.96 (73.13) | 139.82 (64.84) | 140.85 (65.67) |
FBG ≤ 100 mg/dL | 19 (27.14) | 1 (50.00) | 52 (29.21) | 8 (32.00) | 23 (27.71) | 84 (29.17) | 103 (28.77) |
Last PPBG measurement (mg/dl) | 173.70 (79.40) | 81.00 (0.00) | 186.70 (85.41) | 206.63 (100.25) | 192.65 (111.21) | 189.76 (94.86) | 185.97 (91.51) |
No. of people achieving global target* | 3 (4.69) | 0 (0.00) | 6 (3.45) | 0 (0.00) | 1 (1.18) | 7 (2.45) | 10 (2.86) |
People with diabetes-related complications | 44 (59.46) | 1 (50.00) | 117 (64.29) | 19 (73.08) | 72 (81.82) | 209 (70.13) | 253 (68.01) |
People with microvascular complications | 43 (58.11) | 1 (50.00) | 112 (61.54) | 18 (69.23) | 71 (80.68) | 202 (67.79) | 245 (65.86) |
People with macrovascular complications | 2 (2.70) | 0 (0.00) | 21 (11.54) | 5 (19.23) | 14 (15.91) | 40 (13.42) | 42 (11.29) |
Hypoglycemia in the preceding three months | 36 (49.32) | 0 (0.00) | 24 (13.11) | 13 (48.15) | 24 (27.27) | 61 (20.33) | 97 (26.01) |
Severe hypoglycemiain the past 12 months | 15 (21.43) | 0 (0.00) | 6 (3.26) | 4 (14.81) | 7 (8.24) | 17 (5.70) | 32 (8.70) |
Hospitalisations due to diabetes in the past 12 months | 32 (42.67) | 0 (0.00) | 22 (12.22) | 10 (40.00) | 26 (29.89) | 58 (19.73) | 90 (24.39) |